Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

Yi Yang, 1,* Yanzhao Zhou, 2, 3,* Xinyuan Zhang, 1,* Yujing Xin, 1 Yi Chen, 1, 4 Qingsheng Fan, 5 Xiao Li, 1 Xi Wei, 6 Qiang Li, 3 Xiang Zhou, 1 Jinxue Zhou 2 1Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy...

Full description

Bibliographic Details
Main Authors: Yang Y, Zhou Y, Zhang X, Xin Y, Chen Y, Fan Q, Li X, Wei X, Li Q, Zhou X, Zhou J
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
radiofrequency ablation
recurrence-free survival
age-male-albi-platelets score
Online Access:https://www.dovepress.com/using-the-amap-risk-score-to-predict-late-recurrence-following-radiofr-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/using-the-amap-risk-score-to-predict-late-recurrence-following-radiofr-peer-reviewed-fulltext-article-JHC

Similar Items